Sitting for more than 30 minutes at a time is linked to a higher risk of dying from cancer, while breaking up long sitting spells with light activity appeared to lower that risk, according to new data. But media reports on ...
Jul 7, 2026
0
7
Researchers at The University of Texas MD Anderson Cancer Center were able to eradicate measurable residual disease (MRD) in B-cell acute lymphoblastic leukemia (ALL) patients, a critical step in improving long-term survival ...
Jul 7, 2026
0
6
A new Northwestern Medicine study has discovered how radiotherapy alters the immune environment within cutaneous T-cell lymphoma (CTCL) tumors, according to findings published in the Journal of the American Academy of Dermatology.
Jul 7, 2026
0
3
Researchers from Fox Chase Cancer Center have identified a widely used thyroid hormone that may significantly improve treatment outcomes for medulloblastoma, the most common malignant brain tumor in children. The study found ...
Jul 7, 2026
0
7
A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates and was associated with significantly lower mortality, according to new research published in the ...
Jul 7, 2026
0
6
Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for thousands of patients with lung cancer driven by a rare type of KRAS mutation, offering hope for ...
Jul 7, 2026
0
6
Meningiomas are the most common brain tumors in adults, accounting for 38% to 42% of all primary central nervous system tumors. According to 2021 WHO data, 874 million of the world's 1.9 billion women of reproductive age ...
Researchers at the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute report that combining CAR T cell immunotherapy with a targeted radiopharmaceutical significantly improved tumor regression ...
Jul 7, 2026
0
10
If you're a woman newly diagnosed with breast cancer, treatment can feel ... well, scary. Will chemotherapy work? Or will it become a cycle of educated guesswork: trying one drug combination, waiting, scanning? If the tumor ...
Jul 7, 2026
0
8
Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine ...
Jul 7, 2026
0
6
